Skip to main content

U.S. Physical Therapy, Inc. (USPH) Stock Analysis

Falling Knife setup

SellVALUE-TRAP 1/5Moderate Confidence

Healthcare · Medical Care Facilities

Earnings in 6 days (2026-05-06). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. Momentum 1.1/10 is below the 5.0 floor at $70.38 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Earnings in 6 days (event risk); Weak overall score: 4.8/10.

U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and... Read more

$70.38+28.6% A.UpsideScore 4.8/10#25 of 27 Medical Care Facilities
Stop $67.35Target $90.48(analyst − 13%)A.R:R 3.8:1
Analyst target$104.00+47.8%6 analysts
$90.48our TP
$70.38price
$104.00mean
$113

Sell if holding. Momentum 1.1/10 is below the 5.0 floor at $70.38 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Earnings in 6 days (event risk); Weak overall score: 4.8/10. Chart setup: Death cross, below all MAs, RSI 26, MACD bearish. Score 4.8/10, moderate confidence.

Passes 5/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA) and earnings proximity 6d<=7d. Suitability: aggressive.

Thesis

Rewards
Analyst upside: 29%
Risks
Earnings in 6 days (event risk)
Weak overall score: 4.8/10
Negative momentum

Key Metrics

P/E (TTM)50.4
P/E (Fwd)21.4
Mkt Cap$1.1B
EV/EBITDA16.0
Profit Mgn5.1%
ROE7.6%
Rev Growth12.5%
Beta1.35
Dividend2.53%
Rating analysts13

Quality Signals

Piotroski F6/9

Options Flow

P/C1.71bearish
IV72%elevated
Max Pain$40-43.2% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Volume
0.0
Obv
1.0
Ma Position
1.5
Rsi
3.0
Capitulation risk (RSI 26, below 200MA)Volume distribution (falling OBV)Below 200-MA, MA slope flat

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Value Rank
1.7
Quality Rank
3.6
Growth Rank
6.2
GatesMomentum 1.1<4.5Death cross (50MA < 200MA)EARNINGS PROXIMITY 6d<=7dA.R:R 3.8 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARFalling KnifeSuitability: Aggressive
RSI
26 · Oversold
20D MA 50D MA 200D MADEATH CROSSSupport $69.43Resistance $79.48

Price Targets

$67
$90
A.Upside+28.6%
A.R:R3.8:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Momentum score 1.1/10 — below 4.5 minimum
! Death cross — 50-day MA below 200-day MA
! EARNINGS_PROXIMITY:6d<=7d

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-05-06 (6d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is USPH stock a buy right now?

Sell if holding. Momentum 1.1/10 is below the 5.0 floor at $70.38 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Earnings in 6 days (event risk); Weak overall score: 4.8/10. Chart setup: Death cross, below all MAs, RSI 26, MACD bearish. Prior stop was $67.35. Score 4.8/10, moderate confidence.

What is the USPH stock price target?

Take-profit target: $90.48 (+28.6% upside). Prior stop was $67.35. Stop-loss: $67.35.

What are the risks of investing in USPH?

Earnings in 6 days (event risk); Weak overall score: 4.8/10; Negative momentum.

Is USPH overvalued or undervalued?

U.S. Physical Therapy, Inc. trades at a P/E of 50.4 (forward 21.4). TrendMatrix value score: 5.7/10. Verdict: Sell.

What do analysts say about USPH?

13 analysts cover USPH with a consensus score of 4.2/5. Average price target: $104.

What does U.S. Physical Therapy, Inc. do?U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics....

U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.

Related stocks: AVAH (Aveanna Healthcare Holdings Inc) · ADUS (Addus HomeCare Corporation) · UHS (Universal Health Services, Inc.) · CON (Concentra Group Holdings Parent) · ASTH (Astrana Health Inc.)